Federal Judge Assigns More Than Two Dozen Attorneys to Leadership Positions in Zantac Cancer MDL

The federal judge overseeing the Zantac multidistrict litigation (MDL) has chosen more than two dozen plaintiffs’ attorneys to serve in leadership positions in the growing litigation over the recalled heartburn drug Zantac and its potential to cause cancer in users. After interviewing 62 attorneys involved in the Zantac MDL, U.S. District Judge Robin L. Rosenberg […]

Federal Judge Assigns More Than Two Dozen Attorneys to Leadership Positions in Zantac Cancer MDL Read More »